Islet-cell Tumour Causing Hypoglycaemia in a Newborn Infant
Hypoglycaemia due to islet-cell tumour is rare in children, and there have been few reports of its occurrence in newborn infants. Cases in which tumours were found post mortem have been described by Scholten and Van der Vegt (1960) , Bernheim et al. (1961) , and Franqois et al. (1962) .
More recently, Salinas et al. (1968) and Garces, Drash, and Kenny (1968) described 2 infants with persistent hypoglycaemia which was relieved by resection of islet-cell tumours several weeks after delivery. 2 further infants with congenital isletcell tumours have been briefly reported by Drash et al. (1968) and Mann, Rayner, and Gourevitch (1969) .
We wish to describe a further infant with an islet-cell tumour which caused severe hypoglycaemia soon after birth.
Case Report
The patient was a girl born at term weighing 4-1 kg. 2 hours after delivery she had a cyanotic attack, and her blood sugar was subsequently found to be less than 10 mg./100 ml. 2-hourly feeds with added carbohydrate were given, together with intravenous infusions of glucose and fructose, but her hypoglycaemia persisted and she was transferred to this hospital at the age of 5 weeks. On admission she was an obese, unresponsive infant. Her weight was 4 8 kg., her length 53 cm., and her head circumference 38 5 cm. No focal neurological signs were found, but occasional myoclonic jerks were seen.
Her treatment after admission is shown in the Fig. Attempts to control her hypoglycaemia by means of frequent feeding (8 g. SMA, Wveth, and 4 g. carbohydrate, 2-hourly) were unsuccessful, and treatment with increasing doses of diazoxide (up to 20 mg./kg. per day) and chlorothiazide (15 mg./kg. per day) was given. As her hypoglycaemia persisted, and as she was sensitive to I-leucine (see below), her dietary leucine was restricted to 100 mg./kg. per day. This measure was also ineffective and she continued to have brief convulsions which could be rapidly controlled by giving glucose through a naso-gastric tube. Though she gained 2 kg. in 9 weeks, there was no change in her head circumference and she showed little evidence of mental development. below 50 mg./100 ml. were obtained 90-120 minutes after a morning feed during the period of treatment with diazoxide, chlorothiazide and a low leucine diet. During the first 3 days after operation the values ranged from 228 mg./100 ml. to 395 mg./100 ml. Subsequent blood sugar values 4-8 hours after a feed ranged from 47 mg./100 ml. to 87 mg./100 ml.
Before operation, serum insulin levels between 25 ILU/ml. and 37 ±U/ml. were obtained at times when the blood sugar was less than 50 mg./100 ml. After operation, insulin values between 2 ILU/ml. and 10 ±U/ml. were obtained 8 hours after a feed.
The results of the leucine and glucagon tests are given in the Table. Before operation, leucine provoked a (Grant, 1968 (Schwartz et al., 1955) or showed only minor histological changes (Crigler, 1962) . In others, islet-cell tumours or generalized islet-cell hyperplasia (Haddad et al., 1962) were found.
Differentiation between insulinoma and a generalized , cell abnormality may be difficult as leucine sensitivity may be present in either condition (Haddad et al., 1962; Garces et al., 1968) . The clinical features of the present case suggested that hypoglycaemia was due to excessive insulin secretion. Though the laboratory findings confirmed this impression, they were not considered diagnostic of insulinoma, and uncertainty as to the cause of hyperinsulinism led us to start treatment with diazoxide. This drug has been used in the management of a number of children with hypoglycaemia, either alone or in combination with a thiazide, and has been found to inhibit leucineinduced insulin secretion in children with leucinesensitive hypoglycaemia (Baker et al., 1967) . However, treatment with diazoxide was unsuccessful in 3 infants with congenital islet-cell tumours (Salinas et al., 1968; Garces et al., 1968; . It was also ineffective in the present case, and it appears that failure to respond to diazoxide may be almost a diagnostic feature in infants with islet-cell tumours.
Failure of diazoxide therapy in our patient, together with clear evidence of hyperinsulinism, left little choice other than surgical treatment. After removal of her tumour she showed a remarkable improvement. Though it is still too early to assess whether she has completely escaped the neurological sequelae of severe hypoglycaemia, she showed rapid developmental 'catch up' after operation and her head began to grow. Similar improvement was noted in the cases described by Salinas et al. (1968) and Garces et al. (1968) , and it has been suggested that the late prognosis after removal of an insulinoma is better than that in other forms of infantile hypoglycaemia (Crigler, 1962) . Summary The clinical features of an infant with an islet-cell tumour are described. Hypoglycaemia, which began 2 hours after delivery, failed to respond to treatment with diazoxide, chlorothiazide, and a low leucine diet but was relieved by removal of the tumour at the age of 14 weeks. Rapid developmental 'catch up' occurred after the operation. 
Suspending Agents in Medicaments as Possible Sources of Galactose to Galactosaemic Child
The need to exclude galactose from the diet of galactosaemic patients is well understood, and the difficulties of achieving this have been well documented. As little as 250 mg. lactose administered daily as a tablet excipient to a galactosaemic child has been reported sufficient to arrest weight gain (Bower and Smallpeice, 1955) .
Tragacanth and acacia (gum arabic) are widely used as suspending agents in pharmaceutical liquid preparations; for example several of the BPC or NF oral suspensions, and sulphadimidine paediatric mixture BNF. Both these gums, as well as carrageenan (Irish Moss) and agar, are used extensively in the food industry. All four are complex galactosides, and therefore potential sources of galactose. A galactosaemic child prescribed two suspensions concurrently for 6-hourly administration would receive 40 ml. of mixture equivalent to 500 mg. gum daily, in addition to intake from foods and confectionery products.
The purpose of our investigation was to find whether these compounds may be hydrolysed in vivo to free galactose.
Experimental Work
The concentrations of tragacanth, acacia, agar, and carrageenan used in the following experiments were those normally found in liquid pharmaceuticals and foods. In each experiment, products of hydrolysis were demonstrated by thin-layer chromatography.
(1) Each gum was heated with strong acid at 100 'C.
for 4 hours. Products of hydrolysis were demonstrated on Silica Gel G absorbent using chloroform/acetic acid/ water (6/7/1) as solvent and oc-naphthol/sulphuric acid for visualization.
(2) Each material was incubated at 37 'C. with crude malt diastase (o-and ,B-amylase) for 2 hours.
(3) A solution of each gum was incubated with human salivary amylase together with a jejunal biopsy specimen of proven normal lactase activity. Each solution was adjusted to pH in the presence of chloride ions (0-1 %), and incubated at 37 'C. Controls of starch for x-amylase activity, and lactose for lactase activity were incubated to confirm suitable conditions for enzymic digestion.
(4) Solutions, and controls as above, were incubated with hog pancreatic a-amylase and humandisaccharidase. Each tube was adjusted to pH 6-5, and incubated at 37°C.
Several chromatographic systems were examined, and optimum separation was found with cellulose MN 300 as adsorbent 250 ± thick, and ethyl acetate/pyridine/ water (2/1/2) as solvent. Using aniline phthalate for visualization, 0 5 vg. galactose could be detected. This procedure was used in all experiments except (1).
Results
The results are shown in the 
